European Society of Toxicology In Vitro > Uncategorized > ESTIV welcomes two new corporate members!
26 July 2021

ESTIV welcomes two new corporate members!

React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use.For more information visit:
www.react4life.com
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, Symrise has set up an animal testing policy in 2009 that aims to minimize such testing and Symrise is promoting alternative approaches wherever possible.


For more information visit:
www.symrise.com

Related content

Renewal of the ESTIV Board: Call for Applications

  • News

As is customary with any society, the terms of several board members are set to conclude after a certain time. We are now seeking new enthusiastic members who can join our team and help build upon the great work of our colleagues

👨‍🔬👩‍🔬 If you are passionate about promoting in vitro and in silico toxicology and contributing to the advancement of the field, we encourage you to apply!

The Latest in Liver Toxicity Assessment In Vitro

We’re excited to announce that registration is now open for the upcoming joint ASCCT-ESTIV webinar titled “The Latest in Liver Toxicity Assessment In Vitro,” which will feature presentations by Magnus Ingelman-Sundberg, PhD, BSc.Med from the Karolinska Institutet, and Mathieu Vinken, PhD, PharmD, ERT from Vrije Universiteit Brussel.

ESTIV Applied training course will be organised on May 29 – June 2 in Bratislava, Slovakia

  • News

The training course will be held in Bratislava, Slovakia, from May 29 to June 3, 2023. It is open to toxicologists, risk assessors, and other professionals interested in expanding their knowledge of #invitro and #insilico toxicology. Led by experts in the field, the course will provide you with hands-on training and practical experience that you can apply to your work. Don’t miss this opportunity to learn from the best in the field!

Gold Sponsor

Memorandum of Understanding